Search

Author/Creator Borbath, Ivan

2. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial. Issue 8 (August 2022)

Authors:
Kelley, Robin Kate; Rimassa, Lorenza; Cheng, Ann-Lii; Kaseb, Ahmed; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philipp...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 8(2022)
Page Start:
995
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Diagnostic and Therapeutic Roles of Endoscopic Ultrasound in Pediatric Pancreaticobiliary Disorders. Issue 2 (August 2015)

Authors:
Scheers, Isabelle; Ergun, Meltem; Aouattah, Tarik; Piessevaux, Hubert; Borbath, Ivan; Stephenne, Xavier; De Magnée, Catherine; Reding, Raymond; Sokal, Etienne; Veyckemans, Francis; Weynand, Birgit; Deprez, Pierre H.
Journal:
Journal of pediatric gastroenterology and nutrition
Issue:
Volume 61:Issue 2(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Diagnostic and Therapeutic Roles of Endoscopic Ultrasound in Pediatric Pancreaticobiliary Disorders. Issue 2 (August 2015)

Authors:
Scheers, Isabelle; Ergun, Meltem; Aouattah, Tarik; Piessevaux, Hubert; Borbath, Ivan; Stephenne, Xavier; De Magnée, Catherine; Reding, Raymond; Sokal, Etienne; Veyckemans, Francis; Weynand, Birgit; Deprez, Pierre H.
Journal:
Journal of pediatric gastroenterology and nutrition
Issue:
Volume 61:Issue 2(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial. (June 2019)

Authors:
Merle, Philippe; Blanc, Jean-Frederic; Phelip, Jean-Marc; Pelletier, Gilles; Bronowicki, Jean-Pierre; Touchefeu, Yann; Pageaux, Georges; Gerolami, René; Habersetzer, François; Nguyen-Khac, Eric; Casadei-Gardini, Andrea; Borbath, Ivan; Tran, Albert; Wege, Henning; Saad, Amr Shafik; Colombo, Massim...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 4:Number 6(2019)
Page Start:
454
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results. (November 2021)

Authors:
Pavel, Marianne; Ćwikła, Jaroslaw B.; Lombard-Bohas, Catherine; Borbath, Ivan; Shah, Tahir; Pape, Ulrich F.; Capdevila, Jaume; Panzuto, Francesco; Truong Thanh, Xuan-Mai; Houchard, Aude; Ruszniewski, Philippe
Journal:
European journal of cancer
Issue:
Volume 157(2021)
Page Start:
403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors. (1st March 2022)

Authors:
Borbath, Ivan; Pape, Ulrich‐Frank; Deprez, Pierre H.; Bartsch, Detlef Klaus; Caplin, Martyn; Falconi, Massimo; Garcia‐Carbonero, Rocio; Grozinsky‐Glasberg, Simona; Jensen, Robert T.; Arnold, Rudolf; Ruszniewski, Philippe; Toumpanakis, C.; Valle, Juan W.; O´Toole, Dermot
Other Names:
Belli S. H. investigator.; Castaño J. P. investigator.; Chen J investigator.; Costa F. P. investigator.; Couvelard A investigator.; de Herder W. W. investigator.; Deroose C. M. investigator.; Dromain C investigator.; Faggiano A investigator.; Falkerby J investigator.; Fazio N investigator.; Frill...
Journal:
Journal of neuroendocrinology
Issue:
Volume 34:Number 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours. Issue 5 (May 2017)

Authors:
Lepage, Côme; Dahan, Laetitia; Bouarioua, Nadia; Toumpanakis, Christos; Legoux, Jean-Louis; Le Malicot, Karine; Guimbaud, Rosine; Smith, Denis; Tougeron, David; Lievre, Astrid; Cadiot, Guillaume; Di Fiore, Frédéric; Bouhier-Leporrier, Karine; Hentic, Olivia; Faroux, Roger; Pavel, Marianne; Borbat...
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 5(2017)
Page Start:
568
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. (October 2021)

Authors:
Javle, Milind; Roychowdhury, Sameek; Kelley, Robin Kate; Sadeghi, Saeed; Macarulla, Teresa; Weiss, Karl Heinz; Waldschmidt, Dirk-Thomas; Goyal, Lipika; Borbath, Ivan; El-Khoueiry, Anthony; Borad, Mitesh J; Yong, Wei Peng; Philip, Philip A; Bitzer, Michael; Tanasanvimon, Surbpong; Li, Ai; Pande, A...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 6:Number 10(2021)
Page Start:
803
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗